Achieving Self-directed Integrated Cancer Aftercare (ASICA) in Melanoma

University of Aberdeen

Status

Completed

Conditions

Melanoma

Treatments

Other: ASICA digital app

Study type

Interventional

Funder types

Other

Identifiers

NCT03328247

2-028-17

Details and patient eligibility

About

The ASICA study is looking at how the UK National Health Service (NHS) might use technology in the future to more effectively support people who have been treated for melanoma.

Full description

All patients who have been treated for melanoma are advised to regularly examine their own skin (total-skin-self-examinations; TSSE) but research has found that many people are not shown how to do this effectively. We are investigating whether a digital app we have developed (ASICA) can help people with melanoma to use a hand-held tablet computer to do more regular and effective TSSE, and whether this would lead to earlier detection of recurrent and new primary melanomas. The ASICA app also uses the internet to enable people to electronically communicate the findings of their TSSE to a specialist nurse. All those who consent to take part in the study will be randomly allocated into one of two groups. One group will use the ASICA app in addition to their normal follow-up, the other group will continue to attend their routine melanoma follow-up only. Participants will be recruited from two UK sites - NHS Grampian and Cambridge University Hospitals.

Enrollment

240 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Adult (≥18)
Patients treated for stage 0-2C cutaneous melanoma within the preceding 24 months

Exclusion criteria

Stage 3 and 4 melanoma.
Previous local recurrence of melanoma within last 24 months.
Patients who are unable to consent and/or complete questionnaires (e.g. due to cognitive or language issues).
Patients who are blind or visually impaired.